Ulcerative Colitis

Resource Center

Pearls of Wisdom

Research Summaries

Research Summary

Research Summary

Noninvasive Biomarkers Can Be Used For Monitoring and Managing Ulcerative Colitis

03/22/2023

Jessica Ganga

The American Gastroenterological Association (AGA) released a set of guidelines that outlines the use of biomarkers to treat and monitor ulcerative colitis in patients.

03/22/2023

treatment

Efficacy of Biologics and Small Molecule Drugs for Moderate-to-Severe Ulcerative Colitis

09/30/2022

treatment

treatment

Fecal Microbiota Transplantation May Be a Viable Option for Treating Ulcerative Colitis

08/29/2022

Ulcerative Colitis

FDA Approves Option for Pediatric Ulcerative Colitis

02/25/2021

The FDA has approved Humira (Adalimumab) for the treatment of moderately to severly active ulcerative colitis (UC) in pediatric patients aged 5 years or older.

02/25/2021

Ulcerative Colitis

AGA Releases Guideline for Management of Moderate to Severe UC

01/14/2020

The guideline authors developed more than 10 recommendations with the goal of promoting high-quality, high-value, evidence-based care for adult patients with moderate to severe ulcerative colitis.

01/14/2020

March 2023

Current Issue

March 2023

Volume 63

Issue 3